These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 36429042)

  • 21. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
    Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
    Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
    Li H; Yang Y; Hong W; Huang M; Wu M; Zhao X
    Signal Transduct Target Ther; 2020 Jan; 5(1):1. PubMed ID: 32296011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
    Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
    ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in the Production of Genome-Edited Rats.
    Sato M; Nakamura S; Inada E; Takabayashi S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing.
    Ferreira P; Choupina AB
    Mol Biol Rep; 2022 Jul; 49(7):7079-7086. PubMed ID: 35716290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in CRISPR/Cas9-based genome editing for enhancing plant disease resistance.
    Boubakri H
    Gene; 2023 May; 866():147334. PubMed ID: 36871676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application and development of genome editing technologies to the Solanaceae plants.
    Yamamoto T; Kashojiya S; Kamimura S; Kameyama T; Ariizumi T; Ezura H; Miura K
    Plant Physiol Biochem; 2018 Oct; 131():37-46. PubMed ID: 29523384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
    Rasoulinejad SA; Maroufi F
    Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock.
    Yuan YG; Liu SZ; Farhab M; Lv MY; Zhang T; Cao SX
    Funct Integr Genomics; 2024 May; 24(3):81. PubMed ID: 38709433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
    Nguyen Q; Lim KRQ; Yokota T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications.
    Akram F; Sahreen S; Aamir F; Haq IU; Malik K; Imtiaz M; Naseem W; Nasir N; Waheed HM
    Mol Biotechnol; 2023 Feb; 65(2):227-242. PubMed ID: 35474409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research on genodermatoses using novel genome-editing tools.
    Lehmann J; Seebode C; Emmert S
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the impact of chromatin conformation on genome editing tools.
    Chen X; Rinsma M; Janssen JM; Liu J; Maggio I; Gonçalves MA
    Nucleic Acids Res; 2016 Jul; 44(13):6482-92. PubMed ID: 27280977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases.
    Dong M; Liu J; Liu C; Wang H; Sun W; Liu B
    Pharmacol Res; 2022 Nov; 185():106480. PubMed ID: 36191879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
    Chang CY; Ting HC; Su HL; Jeng JR
    Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.